These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1213 related items for PubMed ID: 26169124

  • 41. Polysaccharide isolated from persimmon leaves (Diospyros kaki Thunb.) suppresses TGF-β1-induced epithelial-to-mesenchymal transition in A549 cells.
    Lim WC, Choi JW, Song NE, Cho CW, Rhee YK, Hong HD.
    Int J Biol Macromol; 2020 Dec 01; 164():3835-3845. PubMed ID: 32835798
    [Abstract] [Full Text] [Related]

  • 42. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-β1/Smad2/Smad3 signaling.
    Ye M, Yu M, Yang D, Li J, Wang H, Chen F, Yu H, Shen T, Zhu Q, Zhou C.
    Ecotoxicol Environ Saf; 2020 Jun 01; 195():110464. PubMed ID: 32171946
    [Abstract] [Full Text] [Related]

  • 43. Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells.
    Xu Y, Lou Z, Lee SH.
    Biochem Biophys Res Commun; 2017 Nov 18; 493(2):934-939. PubMed ID: 28951214
    [Abstract] [Full Text] [Related]

  • 44. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors.
    Zhao L, Liu S, Che X, Hou K, Ma Y, Li C, Wen T, Fan Y, Hu X, Liu Y, Qu X.
    Int J Mol Med; 2015 Sep 18; 36(3):645-52. PubMed ID: 26133118
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition.
    Yuan XW, Wang DM, Hu Y, Tang YN, Shi WW, Guo XJ, Song JG.
    J Biol Chem; 2013 Oct 25; 288(43):31206-16. PubMed ID: 24022481
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition.
    Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J, Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, Chen XF.
    Mol Cell Biochem; 2011 Sep 25; 355(1-2):309-14. PubMed ID: 21695462
    [Abstract] [Full Text] [Related]

  • 50. Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition.
    Chen PN, Yang SF, Yu CC, Lin CY, Huang SH, Chu SC, Hsieh YS.
    Environ Toxicol; 2017 Aug 25; 32(8):2053-2063. PubMed ID: 28371048
    [Abstract] [Full Text] [Related]

  • 51. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F, Liu T, Jin H, Wang W.
    Can J Physiol Pharmacol; 2018 Jan 25; 96(1):1-7. PubMed ID: 28177668
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY.
    Biomed Pharmacother; 2018 Feb 25; 98():214-221. PubMed ID: 29268242
    [Abstract] [Full Text] [Related]

  • 54. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis.
    Qi HW, Xin LY, Xu X, Ji XX, Fan LH.
    J Transl Med; 2014 Jan 24; 12():22. PubMed ID: 24456611
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G, Sun B, Gong T, Pan Z, Meng Q, Ju W.
    Phytomedicine; 2019 Mar 15; 56():126-135. PubMed ID: 30668333
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
    Li T, Zhao N, Lu J, Zhu Q, Liu X, Hao F, Jiao X.
    Bioengineered; 2019 Dec 15; 10(1):282-291. PubMed ID: 31311401
    [Abstract] [Full Text] [Related]

  • 59. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
    Zhao R, Gong L, Li L, Guo L, Zhu D, Wu Z, Zhou Q.
    Exp Cell Res; 2013 Mar 10; 319(5):740-9. PubMed ID: 23137649
    [Abstract] [Full Text] [Related]

  • 60. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC, Tsao TC, Hsu SR, Wang HC, Tsai TC, Kao JY, Way TD.
    J Agric Food Chem; 2012 Oct 03; 60(39):9863-73. PubMed ID: 22957988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.